Division News

With the onset of COVID-19, Stanford Health Care (SHC)’s Division of Hospital Medicine faced an increase in patient admissions, which were already high after the recent opening of 500P. SHC and the division responded to this upward trend in patient volumes — which continued even after COVID infection rates began to decline — with a series of interventions that reduced physician’s clinical work burden, ensured patient access, and allowed more time for faculty physicians to focus on teaching and research...

Each new generic entry drives down the cost of generic medications. Unfortunately, this pricing model has helped to create severe strains in the generic drug market over the last decade.

Researchers gain insights from the first pharmacogenetics study in the inpatient postoperative setting at Stanford.

The COVID-19 pandemic's ebbs and flows have hidden the growing presence of another widespread disease: Opioid dependence and abuse.

The number of patients with the virus at California hospitals reached a new low this month since the start of the pandemic, with just 611 reported on July 2.

Stanford Medicine researchers find that using in vitro fertilization with testing embryos for inherited diseases would significantly reduce costs.

During this Grand Rounds, experts discuss "Fountain of Creativity or Pandora's Box? Large Language Models in Healthcare: From Concept to Application." Presenter: Ron Li, MD, Clinical Assistant Professor of Hospital Medicine, Jonathan Chen, MD, PhD, Assistant Professor of Medicine - Biomedical Informatics.

"We have a market that's totally just focused on price" at the expense of safety and ensuring availability, says Dr. Kevin Schulman, a professor of medicine and business at Stanford University.